CPRIT Awards $23 million to UT Health San Antonio and affiliated researchers
Cancer research at The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is getting a $23 million boost from the Cancer Prevention and Research Institute of Texas (CPRIT).
Various laboratories of UT Health San Antonio will benefit from $5.6 million in new CPRIT support, while an additional $3 million will expand drug development research conducted at both the health science center and The University of Texas at San Antonio. Meanwhile, a Dallas life sciences company co-founded by one of UT Health San Antonio’s academic cancer leaders will receive a CPRIT award of $14.4 million. The company is testing a first-in-class cancer drug in a phase 1 clinical trial at the Mays Cancer Center, home to UT Health San Antonio MD Anderson.
